Update: Ybox-01

: Keep the button pressed with the paperclip. While holding it, plug in the power cord.

The first-in-human trial of YBox-01 initiated in late 2023. This open-label, dose-escalation study utilizes a standard 3+3 design to evaluate the safety and maximum tolerated dose (MTD) in patients with advanced solid tumors who have exhausted standard therapies. ybox-01 update

Verdict